Dr. Jody Corey-Bloom’s succinct, comprehensive, and up-to-the-minute annual overview of Huntington’s disease clinical research and trials. https://t.co/NV7Dtep2Yc
With $1 million grant from @HDFCures@harvardmed Mouro Pinto Lab is deploying CRISPR to target genetic modifiers of somatic expansion in #HuntingtonsDisease, testing an experimental drug in mice to deactivate harmful MLH3 scissors #CureHD@HDSA@Help4HDI https://t.co/dXyhD01VAr
In this review article, Dr Jenny Morton of @Cambridge_Uni argues that studies in HD animals provide compelling evidence that sleep and circadian deficits should be better studied in humans.
➡️https://t.co/ngovz0A3ww
#Huntingtonsdisease#Sleep#HDResearch
It is not necessary to be wealthy to do good. Rather, it is almost always common people who devote their time, skills and heart to caring for others. #ApostolicJourney#Mongolia
This holiday season with fears of World War III and millions needing cures for neurological disorders, cancer, and other maladies let people everywhere and their leaders embrace a new global ethic of #FightDiseaseNotWar@Pontifex@JoeBiden@KremlinRussia_E https://t.co/Slra2HXfw5
Journal of Huntington’s Disease @journal_hd published my article “Striving for a Realistic and Unapologetic View of #HuntingtonsDisease,” about my blog: since 2005 321 articles giving voice to HD community, exploring history of the cause. #LetsTalkAboutHD https://t.co/Y9mqD5PQeL
Ionis announces European Medicines Agency accepts Marketing Authorization Application of tofersen to treat rare, genetic form of ALS $IONS https://t.co/bEoW5EkUtO